A paradigm shift – From Lab to production with MTP based Modular Plants even for the Pharmaceutical Industry
Fra Freja Astrup
views
Fra Freja Astrup
Flexibility is no longer optional in pharma—it is structural.
This session shares Merck’s journey from lab‑scale modularisation to GMP‑ready modular production using MTP as the backbone. You see how modular plants are qualified, reconfigured and reused across environments.
Engineers gain deep insight into lifecycle management, validation strategy and how orchestration layers replace local HMIs to simplify compliance. The talk is honest about challenges—and clear about benefits.
If you want to understand how modular automation changes both engineering and quality thinking, this is one of the most strategically important sessions of the summit.